Tristel announced the appointment of Christopher Lee as its chief executive officer on Wednesday, effective 1 August, following a competitive selection process.
Tristel
17 June 2026 09:55:29
Source: Sharecast
The AIM-traded infection prevention products maker said Lee would replace Matt Sassone, who is leaving on 30 June to take a worldwide president role with a large US multinational.
Chief financial officer Anna Wasyl will act as interim CEO until Lee joins.
Lee was most recently chief executive of Summit Medical from 2020 to 2025 and previously led Venner Medical International.
Chair Bruno Holthof said Lee’s medical technology experience, “especially in the US”, made him “the ideal person to lead the business” as Tristel pursues further overseas growth.
At 0937 BST, shares in Tristel were down 1.1% at 380.75p.
Reporting by Josh White for Sharecast.com.
See latest RNS on Investegate
N/A
ISIN:
N/A
Exchange: N/A
Sell:
N/A
Buy:
N/A
Change:
Date:
Prices delayed by at least 15 minutes
Compare our accounts
If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
